Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex(R)) through basal iridectomy (Ando) in a pseudophakic patient
Abstract
Purpose: Intravitreal implantation of dexamethasone implant (Ozurdex(R)) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure.
Methods: This is a case report of migration of Ozurdex(R) through basal iridectomy in a pseudophakic patient with iris claw lens. Conclusions: Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex(R) into the anterior chamber and development of corneal edema.